692
Views
194
CrossRef citations to date
0
Altmetric
Reviews

Macrophage infiltration into adipose tissue: initiation, propagation and remodeling

&
Pages 545-556 | Published online: 18 Jan 2017

Bibliography

  • Xu H, Barnes GT, Yang Q et al.: Chronicinflammation in fat plays a crucial role inthe development of obesity-related insulinresistance. J. Clin. Invest. 112, 1821–1830(2003).
  • Describes the observation that macrophages infiltrate adipose tissue inobesity. In addition, these authorsdemonstrate that the presence of adiposetissue macrophages temporally precedessystemic hyperinsulinemia.
  • Weisberg SP, McCann D, Desai M,Rosenbaum M, Leibel RL,Ferrante AW Jr: Obesity is associatedwith macrophage accumulation inadipose tissue. J. Clin. Invest. 112,1796–1808 (2003).
  • Demonstrated increased macrophageinfiltration into white adipose tissue inobese mice and humans. The authorsdemonstrate that the adipose tissuemacrophages are responsible for themajority of inflammatory cytokineproduction and that these cells are derivedfrom the bone marrow.
  • Kintscher U, Hartge M, Hess K et al.:T-lymphocyte infiltration in visceral adiposetissue. A primary event in adipose tissueinflammation and the development ofobesity-mediated insulin resistance.Arterioscler. Thromb. Vasc. Biol. DOI: 10.1161/ATVBAHA.108.165100(2008) (Epub ahead of print).
  • Rausch ME, Weisberg S, Vardhana P,Tortoriello DV: Obesity in C57BL/6J miceis characterized by adipose tissue hypoxiaand cytotoxic T-cell infiltration. Int. J. Obes.(Lond.) 32, 451–463 (2008).
  • Wu H, Ghosh S, Perrard XD et al.: T-cellaccumulation and regulated on activation,normal T cell expressed and secretedupregulation in adipose tissue in obesity.Circulation 115, 1029–1038 (2007).
  • Zechner R, Strauss JG, Haemmerle G,Lass A, Zimmermann R: Lipolysis: pathwayunder construction. Curr. Opin. Lipidol. 16,333–340 (2005).
  • Bornstein SR, Abu-Asab M, Glasow A et al.:Immunohistochemical and ultrastructurallocalization of leptin and leptin receptor inhuman white adipose tissue anddifferentiating human adipose cells inprimary culture. Diabetes 49, 532–538(2000).
  • Christiansen T, Richelsen B, Bruun JM:Monocyte chemoattractant protein-1 isproduced in isolated adipocytes, associatedwith adiposity and reduced after weight lossin morbid obese subjects. Int. J. Obes.(Lond.) 29, 146–450 (2003).
  • Bruun JM, Lihn AS, Pedersen SB,Richelsen B: Monocyte chemoattractantprotein-1 release is higher in visceral thansubcutaneous human adipose tissue (AT):implication of macrophages resident in theAT. J. Clin. Endocrinol. Metab. 90,2282–2289 (2005).
  • Chen A, Mumick S, Zhang C et al.: Dietinduction of monocyte chemoattractantprotein-1 and its impact on obesity. Obes.Res. 13, 1311–1320 (2005).
  • Cinti S, Mitchell G, Barbatelli G et al.:Adipocyte death defines macrophagelocalization and function in adipose tissue ofobese mice and humans. J. Lipid Res.46(11), 2347–2355 (2005).
  • First to demonstrate that macrophagecrown-like structures surround deadadipocytes in white adipose tissue in obesity.
  • Weisberg SP, Hunter D, Huber R et al.:CCR2 modulates inflammatory andmetabolic effects of high-fat feeding. J. Clin.Invest. 116, 115–124 (2006).
  • Kanda H, Tateya S, Tamori Y et al.: MCP-1contributes to macrophage infiltration intoadipose tissue, insulin resistance, andhepatic steatosis in obesity. J. Clin. Invest.116, 1494–1505 (2006).
  • Cancello R, Tordjman J, Poitou C et al.:Increased infiltration of macrophages inomental adipose tissue is associated withmarked hepatic lesions in morbid humanobesity. Diabetes 55, 1554–1561 (2006).
  • Dahlman I, Kaaman M, Olsson T et al.:A unique role of monocyte chemoattractantprotein 1 among chemokines in adiposetissue of obese subjects. J. Clin. Endocrinol.Metab. 90, 5834–5840 (2005).
  • Lee YH, Nair S, Rousseau E et al.:Microarray profiling of isolated abdominalsubcutaneous adipocytes from obese vs nonobesePima Indians: increased expression ofinflammation-related genes. Diabetologia48, 1776–1783 (2005).
  • Voros G, Maquoi E, Demeulemeester D,Clerx N, Collen D, Lijnen HR: Modulationof angiogenesis during adipose tissuedevelopment in murine models of obesity.Endocrinology 146, 4545–4554 (2005).
  • Aprovian CM, Bigomia S, Mott M et al.:Adipose macrophage infiltration isassociated with insulin resistance andvascular endothelial dysfunction in obesesubjects. Arterioscler. Thromb. Vasc. Biol.DOI: 10.1161/ATVBAHA.108.170316(2008) (Epub ahead of print).
  • De Taeye BM, Novitskaya T,McGuinness OP et al.: Macrophage TNF- contributes to insulin resistance and hepaticsteatosis in diet-induced obesity. Am. J.Physiol. Endocrinol. Metab. 293, E713–E725(2007).
  • Suganami T, Nishida J, Ogawa Y:A paracrine loop between adipocytes andmacrophages aggravates inflammatorychanges. Role of free fatty acids and tumornecrosis factor . Arterioscler. Thromb.Vasc. Biol. 25(10), 2062–2068 (2005).
  • Coenen KR, Gruen ML, Chait A,Hasty AH: Diet-induced increases inadiposity, but not plasma lipids, promotemacrophage infiltration into white adiposetissue. Diabetes 56, 564–573 (2007).
  • Lumeng CN, Bodzin JL, Saltiel AR: Obesityinduces a phenotypic switch in adiposetissue macrophage polarization. J. Clin.Invest. 117, 175–184 (2007).
  • Demonstrates for the first time thatM1 classically activated and M2alternatively activated macrophages exist inadipose tissue.
  • Lee JY, Sohn KH, Rhee SH, Hwang D:Saturated fatty acids, but not unsaturatedfatty acids, induce the expression ofcyclooxygenase-2 mediated throughToll-like receptor 4. J. Biol. Chem. 276,16683–16689 (2001).
  • Lee JY, Plakidas A, Lee WH et al.:Differential modulation of Toll-likereceptors by fatty acids: preferentialinhibition by n-3 polyunsaturatedfatty acids. J. Lipid Res. 44, 479–486(2003).
  • Shi H, Kokoeva MV, Inouye K, Tzameli I,Yin H, Flier JS: TLR4 links innateimmunity and fatty acid-induced insulinresistance. J. Clin. Invest. 116(11),3015–3025 (2006).
  • Suganami T, Tanimoto-Koyama K,Nishida J et al.: Role of the Toll-likereceptor 4/NF- B pathway in saturated fattyacid-induced inflammatory changes in theinteraction between adipocytes andmacrophages. Arterioscler. Thromb. Vasc.Biol. 27, 84–91 (2007).
  • Suganami T, Mieda T, Itoh M,Shimoda Y, Kamei Y, Ogawa Y:Attenuation of obesity-induced adiposetissue inflammation in C3H/HeJ micecarrying a Toll-like receptor 4 mutation.Biochem. Biophys. Res. Commun. 354,45–49 (2007).
  • Poggi M, Bastelica D, Gual P et al.:C3H/HeJ mice carrying a toll-likereceptor 4 mutation are protected againstthe development of insulin resistance inwhite adipose tissue in response to a highfatdiet. Diabetologia 50, 1267–1276(2007).
  • Tsukumo DM, Carvalho-Filho MA,Carvalheira JB et al.: Loss-of-functionmutation in Toll-like receptor 4 preventsdiet-induced obesity and insulinresistance. Diabetes 56, 1986–1998(2007).
  • Davis JE, Gabler NK, Walker-Daniels J,Spurlock ME: Tlr-4 deficiency selectivelyprotects against obesity induced by dietshigh in saturated fat. Obesity (Silver Spring)16, 1248–1255 (2008).
  • Todoric J, Loffler M, Huber J et al.: Adiposetissue inflammation induced by high-fat dietin obese diabetic mice is prevented by n-3polyunsaturated fatty acids. Diabetologia 49,2109–2119 (2006).
  • Saraswathi V, Gao L, Morrow JD, Chait A,Niswender KD, Hasty AH: Fish oil increasescholesterol storage in white adipose tissuewith concomitant decreases ininflammation, hepatic steatosis, andatherosclerosis in mice. J. Nutr. 137,1776–1782 (2007).
  • Robker RL, Collins RG, Beaudet AL,Mersmann HJ, Smith CW: Leukocytemigration in adipose tissue of mice null forICAM-1 and Mac-1 adhesion receptors.Obes. Res. 12, 936–940 (2004).
  • Brake DK, Smith EO, Mersmann H,Smith CW, Robker RL: ICAM-1expression in adipose tissue: effects ofdiet-induced obesity in mice. Am. J.Physiol. Cell Physiol. 291, C1232–C1239(2006).
  • Nishimura S, Manabe I, Nagasaki M et al.:In vivo imaging in mice reveals local celldynamics and inflammation in obeseadipose tissue. J. Clin. Invest. 118, 710–721(2008).
  • Curat CA, Miranville A, Sengenes C et al.:From blood monocytes to adipose tissueresidentmacrophages: induction ofdiapedesis by human mature adipocytes.Diabetes 53, 1285–1292 (2004).
  • Frankenberry KA, Somasundar P,McFadden DW, Vona-Davis LC: Leptininduces cell migration and the expressionof growth factors in human prostatecancer cells. Am. J. Surg. 188, 560–565(2004).
  • Goetze S, Bungenstock A, Czupalla Cet al.: Leptin induces endothelial cellmigration through Akt, which is inhibitedby PPAR -ligands. Hypertension 40,748–754 (2002).
  • Oda A, Taniguchi T, Yokoyama M: Leptinstimulates rat aortic smooth muscle cellproliferation and migration. Kobe J. Med.Sci. 47, 141–150 (2001).
  • Ottonello L, Gnerre P, Bertolotto M et al.:Leptin as a uremic toxin interferes withneutrophil chemotaxis. J. Am. Soc. Nephrol.15, 2366–2372 (2004).
  • Wolk R, Deb A, Caplice NM, Somers VK:Leptin receptor and functional effects ofleptin in human endothelial progenitor cells.Atherosclerosis 183, 131–139 (2005).
  • Gruen ML, Hao M, Piston DW, Hasty AH:Leptin requires canonical migratorysignaling pathways for induction ofmonocyte and macrophage chemotaxis.Am. J. Physiol. Cell Physiol. 293,C1481–C1488 (2007).
  • Hosogai N, Fukuhara A, Oshima K et al.:Adipose tissue hypoxia in obesity and itsimpact on adipocytokine dysregulation.Diabetes 56, 901–911 (2007).
  • Ye J, Gao Z, Yin J, He Q: Hypoxia is apotential risk factor for chronicinflammation and adiponectin reduction inadipose tissue of ob/ob and dietary obesemice. Am. J. Physiol. Endocrinol. Metab. 293,E1118–E1128 (2007).
  • Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J:Macrophage infiltration into adipose tissuemay promote angiogenesis for adipose tissueremodeling in obesity. Am. J. Physiol.Endocrinol. Metab. 295, E313–E322 (2008).
  • Wang B, Wood I, Trayhurn P: Hypoxiainduces leptin gene expression and secretionin human preadipocytes: differential effectsof hypoxia on adipokine expression bypreadipocytes. J. Endocrinol. 198, 127–134(2008).
  • Wang B, Wood IS, Trayhurn P:Dysregulation of the expression andsecretion of inflammation-relatedadipokines by hypoxia in human adipocytes.Pflugers Arch. 455, 479–492 (2007).
  • Cinti S, Mitchell G, Barbatelli G et al.:Adipocyte death defines macrophagelocalization and function in adipose tissue ofobese mice and humans. J. Lipid Res. 46,2347–2355 (2005).
  • Murano I, Barbatelli G, Parisani V et al.:Dead adipocytes, detected as crown-likestructures (CLS), are prevalent in visceral fatdepots of genetically obese mice. J. LipidRes. 49, 1562–1568 (2008).
  • Strissel KJ, Stancheva Z, Miyoshi H et al.:Adipocyte death, adipose tissue remodeling,and obesity complications. Diabetes 56,2910–2918 (2007).
  • Demonstrates that as adipose tissueexpands it goes through a phase wherethe majority of adipocytes are dead,followed by a remodeling process thatinvolves adipocyte hyperplasia.
  • Osuga J, Ishibashi S, Oka T et al.:Targeted disruption of hormone-sensitivelipase results in male sterility andadipocyte hypertrophy, but not in obesity.Proc. Natl Acad. Sci. USA 97, 787–792(2000).
  • Okamoto Y, Higashiyama H, Rong JX et al.:Comparison of mitochondrial andmacrophage content between subcutaneousand visceral fat in db/db mice. Exp. Mol.Pathol. 83, 73–83 (2007).
  • Murano I, Barbatelli G, Parisani V et al.:Dead adipocytes, detected as crown-likestructures (CLS), are prevalent in visceral fatdepots of genetically obese mice. J. LipidRes. 49, 1562–1568 (2008).
  • Goossens, GH: The role of adipose tissuedysfunction in the pathogenesis of obesityrelatedinsulin resistance. Physiol. Behav. 94,206–218 (2008).
  • Elgazar-Carmon V, Rudich A, Hadad N,Levy R: Neutrophils transiently infiltrateintra-abdominal fat early in the course ofhigh fat feeding. J. Lipid Res.DOI: 10.1194/jlr.M800132-JLR200(2008) (Epub ahead of print).
  • Leik CE, Walsh SW: Neutrophils infiltrateresistance-sized vessels of subcutaneous fatin women with preeclampsia. Hypertension44, 72–77 (2004).
  • Inouye KE, Shi H, Howard JK et al.:Absence of CC chemokine ligand 2 does notlimit obesity-associated infiltration ofmacrophages into adipose tissue. Diabetes56, 2242–2250 (2007).
  • Kamei N, Tobe K, Suzuki R et al.:Overexpression of monocytechemoattractant protein-1 in adipose tissuescauses macrophage recruitment and insulinresistance. J. Biol. Chem. 281, 26602–26614(2006).
  • Yu R, Kim CS, Kwon BS, Kawada T:Mesenteric adipose tissue-derivedmonocyte chemoattractant protein-1 playsa crucial role in adipose tissue macrophagemigration and activation in obese mice.Obesity (Silver Spring) 14, 1353–1362(2006).
  • Nara N, Nakayama Y, Okamoto S et al.:Disruption of CXC motif chemokineligand-14 in mice ameliorates obesityinducedinsulin resistance. J. Biol. Chem.282, 30794–30803 (2007).
  • Kirk EA, Sagawa ZK, McDonald TO,O’Brien KD, Heinecke JW: Macrophagechemoattractant protein-1 deficiency failsto restrain macrophage infiltration intoadipose tissue. Diabetes 57, 1254–1261(2008).
  • Murdolo G, Hammarstedt A, Sandqvist Met al.: Monocyte chemoattractant protein-1in subcutaneous abdominal adipose tissue:characterization of interstitial concentrationand regulation of gene expression by insulin.J. Clin. Endocrinol. Metab. 92, 2688–2695(2007).
  • Westerbacka J, Corner A, Kolak M et al.:Insulin regulation of MCP-1 in humanadipose tissue of obese and lean women.Am. J. Physiol. Endocrinol. Metab. 294,E841–E845 (2008).
  • Huber J, Kiefer FW, Zeyda M et al.:CC chemokine and CC chemokinereceptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J. Clin.Endocrinol. Metab. DOI: 10.1210/jc.2007-2630 (2008)(Epub ahead of print).
  • Ferenbach D, Kluth DC, Hughes J:Inflammatory cells in renal injury andrepair. Semin. Nephrol. 27, 250–259(2007).
  • Johnson, JL: Matrix metalloproteinases:influence on smooth muscle cellsand atherosclerotic plaque stability.Expert Rev. Cardiovasc. Ther. 5, 265–282(2007).
  • Libby P: Inflammatory mechanisms:the molecular basis of inflammation anddisease. Nutr. Rev. 65, S140–S146(2007).
  • Savill J, Dransfield I, Gregory C, Haslett C:A blast from the past: clearance of apoptoticcells regulates immune responses. Nat. Rev.Immunol. 2, 965–975 (2002).
  • Mantovani A, Sica A, Sozzani S, Allavena P,Vecchi A, Locati M: The chemokine systemin diverse forms of macrophage activationand polarization. Trends Immunol. 25,677–686 (2004).
  • Gordon S, Taylor PR: Monocyteand macrophage heterogeneity.Nat. Rev. Immunol. 5, 953–964(2005).
  • Satriano J: Arginine pathways and theinflammatory response: interregulationof nitric oxide and polyamines: reviewarticle. Amino Acids 26, 321–329(2004).
  • Lumeng CN, Deyoung SM, Bodzin JL,Saltiel AR: Increased inflammatoryproperties of adipose tissue macrophagesrecruited during diet-induced obesity.Diabetes 56, 16–23 (2007).
  • Odegaard JI, Ricardo-Gonzalez RR,Goforth MH et al.: Macrophage-specificPPAR controls alternative activation andimproves insulin resistance. Nature 447,1116–1120 (2007).
  • Stienstra R, Duval C, Keshtkar S,van der Laak J, Kersten S, Muller M:PPAR activation promotes infiltration ofalternatively activated macrophages intoadipose tissue. J. Biol. Chem. 283,22620–22627 (2008).
  • Kang K, Reilly SM, Volkan K et al.:Adipocyte-derived Th2 cytokinesand myeloid PPAR regulatemacrophage polarization and insulinsensitivity. Cell Metab. 7, 485–495(2008).
  • Zeyda M, Farmer D, Todoric J et al.:Human adipose tissue macrophages are ofan anti-inflammatory phenotype butcapable of excessive pro-inflammatorymediator production. Int. J. Obes. (Lond.)31, 1420–1428 (2007).
  • Bourlier V, Zakaroff-Girard A,Miranville A et al.: Remodelingphenotype of human subcutaneousadipose tissue macrophages. Circulation117, 806–815 (2008).
  • Chavey C, Mari B, Monthouel MNet al.: Matrix metalloproteinases aredifferentially expressed in adipose tissueduring obesity and modulate adipocytedifferentiation. J. Biol. Chem. 278,11888–11896 (2003).
  • Maquoi E, Munaut C, Colige A,Collen D, Lijnen HR: Modulationof adipose tissue expression ofmurine matrix metalloproteinasesand their tissue inhibitors withobesity. Diabetes 51, 1093–1101(2002).
  • Van Hul M, Lijnen HR: A functionalrole of gelatinase A in the developmentof nutritionally induced obesity in mice.J. Thromb. Haemost. 6, 1198–1206(2008).
  • Lijnen HR, Demeulemeester D,Van Hoef B, Collen D, Maquoi E:Deficiency of tissue inhibitor ofmatrix metalloproteinase-1 (TIMP-1)impairs nutritionally induced obesity inmice. Thromb. Haemost. 89, 249–255(2003).
  • Demeulemeester D, Collen D, Lijnen HR:Effect of matrix metalloproteinaseinhibition on adipose tissue development.Biochem. Biophys. Res. Commun. 329,105–110 (2005).
  • Lijnen HR, Maquoi E, Hansen LB,Van Hoef B, Frederix L, Collen D: Matrixmetalloproteinase inhibition impairsadipose tissue development in mice.Arterioscler. Thromb. Vasc. Biol. 22,374–379 (2002).
  • Huber J, Loffler M, Bilban M et al.:Prevention of high-fat diet-induced adiposetissue remodeling in obese diabetic mice byn-3 polyunsaturated fatty acids. Int. J. Obes.(Lond.) 31, 1004–1013 (2007).
  • Derosa G, Ferrari I, D’Angelo A et al.: Matrixmetalloproteinase-2 and -9 levels in obesepatients. Endothelium 15, 219–224 (2008).
  • Kralisch S, Bluher M, Tonjes A et al.: Tissueinhibitor of metalloproteinase-1 predictsadiposity in humans. Eur. J. Endocrinol.156, 257–261 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.